Skip to main content
New — The Peptide Dictionary: 128 terms, explained simply
New guide — NAD+ for Anti-Aging: What the Science Says
New guide — GHK-Cu: the copper peptide for your skin
Not sure where to start? — A 60-second quiz points you to the path that fits your goal
New explainer — Semaglutide: what the research says, made simple
Browse — Peptide guides, made simple
New — The Peptide Dictionary: 128 terms, explained simply
New guide — NAD+ for Anti-Aging: What the Science Says
New guide — GHK-Cu: the copper peptide for your skin
Not sure where to start? — A 60-second quiz points you to the path that fits your goal
New explainer — Semaglutide: what the research says, made simple
Browse — Peptide guides, made simple
Easy-to-follow guides
Independent reviews
Vetted providers
Free to read

Home / Peptide legality / Texas

Peptide legality · Texas · updated 2026-09-21

Are peptides legal in Texas?

Gray area

Peptides occupy a legal gray zone in Texas: prescription peptide medicines dispensed through a licensed compounding pharmacy can be lawful, but most popular research peptides are not FDA-approved and cannot be legally sold or marketed for human use anywhere in the state.

Legal status overview

Peptides sit in a legal gray zone in Texas. There is no Texas-specific ban, and the Texas State Board of Pharmacy regulates compounding under the same federal 503A and 503B framework the FDA enforces nationwide, so a peptide prescribed by a licensed clinician and dispensed by a properly licensed compounding pharmacy can be lawful. However, widely marketed research peptides such as BPC-157 and TB-500 are unapproved new drugs that the FDA does not permit to be sold or marketed for human consumption, and the compounded GLP-1 pathways that expanded during the drug shortages have largely closed. Texas is generally viewed as a permissive enforcement environment compared with states like California, but permissive enforcement does not change the underlying federal law.

Key points

  • Texas has no statute that singles out peptides; compounding pharmacies in the state must follow both Texas State Board of Pharmacy rules and the federal 503A and 503B compounding provisions of the Food, Drug, and Cosmetic Act. [4]
  • Texas sterile compounding is governed by Board rule 22 TAC 291.133, which ties beyond-use dating, risk levels, and facility standards to USP Chapter 797, meaning compounded peptide injectables must meet defined pharmacy quality standards. [5]
  • A bulk peptide may be used in 503A compounding only if it has a USP or NF monograph, is a component of an FDA-approved drug, or appears on the FDA 503A bulk drug substances list, and BPC-157 currently meets none of these tests. [2]
  • The FDA determined the semaglutide shortage resolved on February 21, 2025, ending 503A enforcement discretion on April 22, 2025 and 503B enforcement discretion on May 22, 2025, which sharply narrows lawful compounding of Ozempic®-class medicines in Texas. [1]
  • The FDA determined the tirzepatide shortage resolved on December 19, 2024 and ended compounding enforcement discretion in early 2025, so broad compounding of Mounjaro®-class and Zepbound®-class medicines is no longer covered. [6]
  • The FDA scheduled its Pharmacy Compounding Advisory Committee to evaluate several peptides for the 503A bulks list at a July 23 and 24, 2026 meeting, meaning the compounding status of substances like BPC-157 remained under active federal review and unsettled. [3]
  • Research peptides sold with a 'not for human consumption' or 'research use only' label are still unapproved new drugs under federal law, and that label gives sellers and buyers in Texas no legal authorization to use them as medicine. [2]
  • Texas is generally considered a lower enforcement environment for peptide compounding than states such as California, but state enforcement posture does not override the federal restrictions that apply statewide. [1]

Compound-by-compound status

BPC-157
Restricted
Not FDA-approved; not a generic; not evaluated by the FDA. It has no USP monograph and is not on the 503A bulks list, so it cannot be lawfully compounded for human use, and it was under FDA advisory-committee review as of 2026.
GLP-1 class, including Ozempic® (semaglutide), Wegovy® (semaglutide), Mounjaro® (tirzepatide), and Zepbound® (tirzepatide)
Legal
The FDA-approved brand products are legal with a valid prescription. Compounded semaglutide and tirzepatide are not FDA-approved; not a generic; not evaluated by the FDA, and their broad compounding pathways closed after the shortages resolved in 2025, leaving only narrow patient-specific exceptions.
TB-500 (thymosin beta-4 fragment)
Restricted
Not FDA-approved; not a generic; not evaluated by the FDA. It is an unapproved new drug with no approved human indication and cannot be lawfully sold or marketed for human consumption in Texas.
Growth hormone peptides and somatropin
Gray area
Somatropin (recombinant human growth hormone) is an FDA-approved prescription drug whose distribution is federally restricted to approved medical uses, and distribution for non-approved uses is a federal offense. Growth-hormone-releasing peptides such as CJC-1295 and ipamorelin are not FDA-approved; not a generic; not evaluated by the FDA and were placed in the restricted compounding category, while sermorelin occupies a distinct and more permissive compounding position that a licensed pharmacist should verify.

Frequently asked questions

Are peptides legal in Texas?

There is no Texas law that bans peptides outright, so the answer depends on the specific peptide. FDA-approved prescription peptide medicines dispensed through a licensed pharmacy can be legal, but most popular research peptides are unapproved new drugs that cannot be legally sold or used for human consumption. This is information, not legal or medical advice.

Can I get compounded semaglutide or tirzepatide in Texas?

The FDA-approved brand products such as Wegovy® (semaglutide) and Zepbound® (tirzepatide) are available with a prescription. Compounded versions are not FDA-approved; not a generic; not evaluated by the FDA, and the broad compounding pathways closed after the FDA declared the shortages resolved in 2025, leaving only narrow patient-specific circumstances.

Is BPC-157 legal to buy in Texas?

BPC-157 is not FDA-approved and is not authorized for compounding into human medicine, so it cannot be lawfully sold or marketed for human consumption in Texas. Products labeled 'research use only' remain unapproved new drugs under federal law.

Who regulates peptide compounding in Texas?

The Texas State Board of Pharmacy licenses and inspects compounding pharmacies and enforces its rules alongside the federal 503A and 503B provisions overseen by the FDA. Prescribing physicians are separately overseen by the Texas Medical Board.

Does the 'research chemical' label make a peptide legal?

No. Labeling a vial 'not for human consumption' or 'for research use only' does not change a peptide's status as an unapproved new drug, and it provides no legal cover for selling or using it as medicine in Texas.

General information based on the sourced research above, not legal advice. For a specific situation in Texas, consult a licensed attorney familiar with pharmaceutical law.